The FDA thinks an antibody-drug conjugate (ADC ... whose tumours overexpress c-Met. The c-Met protein thought to be both a driver of cancer itself, as well as a resistance mechanism that tumours ...

Teliso-V could become the first antibody-drug conjugate (ADC) targeting c-Met to be approved by the FDA if all goes according to plan, said the pharma group. It is positioning the drug as a ...

This expansion pertains to the development of bispecific antibody-drug conjugates targeting EGFR/cMET, marking a significant ...

Sino Biological Inc. Flow Cytometric Analysis of Human c-Met Expression on HepG2 Cells — 10692-R243. Cells were stained with purified anti-Human c-Met, second antibody conjugated with FITC.

Antibody-drug conjugates (ADCs ... REGN5093-M114, another bispecific ADC, targets cMet and has demonstrated efficacy in ...